|
2025 Journal Article The gut microbiome in B cell lymphomaVickers, Darcy, Martynchyk, Arina, Henden, Andrea, Smibert, Olivia C., Hawkes, Eliza A. and Chong, Geoff (2025). The gut microbiome in B cell lymphoma. Blood Reviews 101357, 101357. doi: 10.1016/j.blre.2025.101357 |
|
2025 Journal Article Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in AustraliaLi, Jian, Dowling, Mark, Jeffrey, Anthony, Farina, Sergio, Boyle, Stephen, MacDonald, Ross, Inam, Shafqat, Ma, Chun Kei Kris, Vanguru, Vinay, Perera, Nilu, Scott, Hamish, Dickinson, Michael, Seymour, John, Henden, Andrea, Blyth, Emily, Ho, Phoebe Joy, Tam, Constantine, Anderson, Mary Ann and Thompson, Philip (2025). Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in Australia. Blood, 146 (Supplement 1), 2779-2779. doi: 10.1182/blood-2025-2779 |
|
2025 Journal Article A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortiumDowling, Mark, Vanguru, Vinay, Boyle, Stephen, Cashion, Catelyn, Inam, Shafqat, Buss, Thomas, Jeffrey, Anthony, Scott, Hamish, MacDonald, Ross, Li, Jian, O'Leary, Nicole, Minson, Adrian, Brown, Christina, Anderson, Mary Ann, Sutrave, Gaurav, Belbachir, Safia, Butler, Jason, Curley, Cameron, Barraclough, Allison, Tam, Constantine, Henden, Andrea, Blyth, Emily, Ho, Phoebe Joy, Harrison, Simon and Dickinson, Michael (2025). A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium. Blood, 146 (Supplement 1), 399-399. doi: 10.1182/blood-2025-399 |
|
2025 Journal Article Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvementCashion, Catelyn, Li, Jian, Farina, Sergio, Inam, Shafqat, Jeffrey, Anthony, MacDonald, Ross, Buss, Thomas, Vanguru, Vinay, Boyle, Stephen, Bishop, David, Brown, Christina, Barraclough, Allison, Tam, Constantine, Henden, Andrea, Dickinson, Michael, Blyth, Emily and Dowling, Mark (2025). Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvement. Blood, 146 (Supplement 1), 1936-1936. doi: 10.1182/blood-2025-1936 |
|
2025 Conference Publication Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphomaBurgess, Melinda, Hawula, Zachary, Tuczko, Nella, Kempe, Sarah, Murigneux, Valentine, Swain, Fiona, Chowdhury, Rakin, Bradbury, Lucy, Antczak, Magdalena, Mehdi, Ahmed, Hawkes, Eliza, Wight, Joel, Henden, Andrea, Sheehy, Joshua, Gandhi, Maher, Jiang, Sizun and Keane, Colm (2025). Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphoma. 67th ASH Annual Meeting and Exposition, Orlando, FL, United States, 6-9 December 2025. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2025-147 |
|
2025 Journal Article Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantationNakagaki, Midori, Hajkowicz, Krispin, Roberts, Jason A and Henden, Andrea S (2025). Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation. Expert Review of Anti-infective Therapy, ahead-of-print (ahead-of-print), 1-14. doi: 10.1080/14787210.2025.2527970 |
|
2025 Journal Article p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practiceNelles, Ricky, Tallack, Michael R., Tate, Courtney, Hunt, Stewart, Aung, Hnin, Henden, Andrea, Jones, Lee and Seymour, Louise (2025). p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice. Pathology, 57 (4), 489-494. doi: 10.1016/j.pathol.2024.11.011 |
|
2025 Journal Article Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignanciesLindsay, Daniel, Henden, Andrea, Nelles, Ricky, Elliott, Thomas M. and Collins, Louisa G. (2025). Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies. Applied Health Economics and Health Policy, 23 (3) 659595, 507-517. doi: 10.1007/s40258-024-00927-8 |
|
2025 Journal Article Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ diseaseHenden, Andrea S, Lineburg, Katie E, Panikkar, Archana, Mahajan, Arushi, Nelles, Ricky, Wright, Emma, Crooks, Pauline, Raju, Jyothy, Le Texier, Laetitia, Swaminathan, Srividhya, Beagley, Leone, Best, Shannon, Solomon, Matthew, Reddiex, Hilary, Kennedy, Glen, Tey, Siok‐Keen, Neller, Michelle A, Khanna, Rajiv and Smith, Corey (2025). Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease. Clinical & Translational Immunology, 14 (6) e70038, e70038. doi: 10.1002/cti2.70038 |
|
2024 Conference Publication Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 MutationNelles, Ricky, Butler, Jason, Curley, Cameron, Henden, Andrea S., Hunt, Stewart, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 Mutation. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-209669 |
|
2024 Conference Publication Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at RelapseSwain, Fiona, Burgess, Melinda, Kempe, Sarah, Sabdia, Muhammed B., Henden, Andrea S., Wight, Joel, Hawkes, Eliza A., Mutsando, Howard, Talaulikar, Dipti, Merida de Long, Lilia, Birch, Simone, Wyche, Penelope, Hawula, Zachary, Chowdhury, Rakin, Gandhi, Maher K. and Keane, Colm (2024). Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-199352 |
|
2024 Conference Publication Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host DiseaseLeung, Becky, Butler, Jason, Curley, Cameron, Henden, Andrea S., Hunt, Stewart, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host Disease. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-210424 |
|
2024 Journal Article Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapySheehy, Joshua, Scott, Ashleigh P., Henden, Andrea S., Kennedy, Glen, Redmond, Andrew M. and Stewart, Adam G. (2024). Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy. Journal of Antimicrobial Chemotherapy, 79 (8), 2040-2047. doi: 10.1093/jac/dkae209 |
|
2024 Journal Article Clinical grade multiparametric cell sorting and gene-marking of regulatory T cellsEkwe, Adaeze Precious, Au, Raymond, Zhang, Ping, McEnroe, Benjamin, Tan, Mei Ling, Saldan, Alda, Henden, Andrea S., Hutchins, Cheryl, Henderson, Ashleigh, Mudie, Kari, Kerr, Keri, Fuery, Madonna, Kennedy, Glen A., Hill, Geoffrey R. and Tey, Siok-Keen (2024). Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells. Cytotherapy, 26 (7), 719-728. doi: 10.1016/j.jcyt.2024.02.023 |
|
2024 Journal Article Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapyPerera, Nilu, Baidya, Shoma, Weber, Nicholas, Mudie, Kari, Butler, Jason, Curley, Cameron, Henden, Andrea, Hunt, Stewart, Subramoniapillai, Elango, Tey, Siok‐Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy. Transfusion, 64 (4), 762-765. doi: 10.1111/trf.17793 |
|
2024 Journal Article IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantationZhang, Ping, Fleming, Peter, Andoniou, Christopher E., Waltner, Olivia G., Bhise, Shruti S., Martins, Jose Paulo, McEnroe, Benjamin A., Voigt, Valentina, Daly, Sheridan, Kuns, Rachel D., Ekwe, Adaeze P., Henden, Andrea S., Saldan, Alda, Olver, Stuart, Varelias, Antiopi, Smith, Corey, Schmidt, Christine R., Ensbey, Kathleen S., Legg, Samuel R.W., Sekiguchi, Tomoko, Minnie, Simone A., Gradwell, Mark, Wagenaar, Irma, Clouston, Andrew D., Koyama, Motoko, Furlan, Scott N., Kennedy, Glen A., Ward, E Sally, Degli-Esposti, Mariapia A. ... Tey, Siok-Keen (2024). IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation. Journal of Clinical Investigation, 134 (7) e174184, 1-15. doi: 10.1172/jci174184 |
|
2023 Conference Publication Feasibility of prebiotic enteral nutrition provision during allogeneic stem cell transplantationAndersen, S., Kennedy, G., Banks, M. and Henden, A. (2023). Feasibility of prebiotic enteral nutrition provision during allogeneic stem cell transplantation. 45th ESPEN Congress 2023, Lyon, France, 11-14 September 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.clnesp.2023.09.012 |
|
2023 Journal Article ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host diseaseHamad, Nada, Bilmon, Ian, Chee, Lynette, Henden, Andrea, Johnston, Anna, Purtill, Duncan, Bajel, Ashish, Tey, Siok‐Keen, Yeung, David, Cole, Theresa, Lewis, Clinton and Butler, Jason (2023). ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease. Internal Medicine Journal, 53 (12), 2319-2329. doi: 10.1111/imj.16255 |
|
2023 Journal Article Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, AustraliaWong, Philip, Whiteman, David C., Olsen, Catherine M., Yuan, Yin, Butler, Jason, Curley, Cameron, Durrant, Simon, Henden, Andrea, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2023). Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia. Bone Marrow Transplantation, 59 (1) s41409-023-02138-6, 144-146. doi: 10.1038/s41409-023-02138-6 |
|
2023 Journal Article Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 yearsPeri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x |
